These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 16276593)

  • 1. Meeting notes from the 3rd IAS Conference. Treating TB and HIV concurrently.
    Friedland GH
    AIDS Clin Care; 2005 Oct; 17(10):98. PubMed ID: 16276593
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nevirapine-based antiretroviral therapy started early in the course of tuberculosis treatment in adult Malawians.
    van Oosterhout JJ; Kumwenda JJ; Beadsworth M; Mateyu G; Longwe T; Burger DM; Zijlstra EE
    Antivir Ther; 2007; 12(4):515-21. PubMed ID: 17668560
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nevirapine levels after discontinuation of rifampicin therapy and 60-week efficacy of nevirapine-based antiretroviral therapy in HIV-infected patients with tuberculosis.
    Manosuthi W; Ruxrungtham K; Likanonsakul S; Prasithsirikul W; Inthong Y; Phoorisri T; Sungkanuparph S
    Clin Infect Dis; 2007 Jan; 44(1):141-4. PubMed ID: 17143831
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Do we still need lead-in dosing of nevirapine in HIV-infected patients who are receiving rifampicin-containing antituberculous therapy?
    Chang SY; Lin SW; Hung CC
    Clin Infect Dis; 2009 Nov; 49(9):1452-3; author reply 1453-4. PubMed ID: 19824849
    [No Abstract]   [Full Text] [Related]  

  • 5. Meeting notes from the 3rd IAS Conference. HIV treatment and risk for metabolic complications.
    Currier J
    AIDS Clin Care; 2005 Oct; 17(10):95-6. PubMed ID: 16276590
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Meeting notes from the 3rd IAS Conference. Advances in the treatment of hepatitis/HIV coinfection.
    Sax PE
    AIDS Clin Care; 2005 Oct; 17(10):97-8. PubMed ID: 16276592
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetics and 48-week efficacy of nevirapine: 400 mg versus 600 mg per day in HIV-tuberculosis coinfection receiving rifampicin.
    Avihingsanon A; Manosuthi W; Kantipong P; Chuchotaworn C; Moolphate S; Sakornjun W; Gorowara M; Yamada N; Yanai H; Mitarai S; Ishikawa N; Cooper DA; Phanuphak P; Burger D; Ruxrungtham K
    Antivir Ther; 2008; 13(4):529-36. PubMed ID: 18672531
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Plasma nevirapine levels and 24-week efficacy in HIV-infected patients receiving nevirapine-based highly active antiretroviral therapy with or without rifampicin.
    Manosuthi W; Sungkanuparph S; Thakkinstian A; Rattanasiri S; Chaovavanich A; Prasithsirikul W; Likanonsakul S; Ruxrungtham K
    Clin Infect Dis; 2006 Jul; 43(2):253-5. PubMed ID: 16779754
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nevirapine plasma concentrations and concomitant use of rifampin in patients coinfected with HIV-1 and tuberculosis.
    Autar RS; Wit FW; Sankote J; Mahanontharit A; Anekthananon T; Mootsikapun P; Sujaikaew K; Cooper DA; Lange JM; Phanuphak P; Ruxrungtham K; Burger DM
    Antivir Ther; 2005; 10(8):937-43. PubMed ID: 16430199
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Meeting notes from the 3rd IAS Conference. Male circumcision: a new prevention strategy?
    Friedland GH
    AIDS Clin Care; 2005 Oct; 17(10):93-4. PubMed ID: 16276588
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of rifampicin-based antitubercular therapy on nevirapine plasma concentrations in South African adults with HIV-associated tuberculosis.
    Cohen K; van Cutsem G; Boulle A; McIlleron H; Goemaere E; Smith PJ; Maartens G
    J Antimicrob Chemother; 2008 Feb; 61(2):389-93. PubMed ID: 18096560
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Co-administration of rifampin and nevirapine in HIV-infected patients with tuberculosis.
    Oliva J; Moreno S; Sanz J; Ribera E; Molina JA; Rubio R; Casas E; Mariño A
    AIDS; 2003 Mar; 17(4):637-8. PubMed ID: 12598789
    [No Abstract]   [Full Text] [Related]  

  • 13. Combination antiretroviral therapy with tenofovir, emtricitabine or lamivudine, and nevirapine.
    Redfield RR; Morrow JS
    Clin Infect Dis; 2008 Oct; 47(7):984-5. PubMed ID: 18778234
    [No Abstract]   [Full Text] [Related]  

  • 14. Meeting notes from the 3rd IAS Conference. New drugs.
    Feinberg J
    AIDS Clin Care; 2005 Oct; 17(10):96-7. PubMed ID: 16276591
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rifampicin plus pyrazinamide versus isoniazid for treating latent tuberculosis infection: a meta-analysis.
    Gao XF; Wang L; Liu GJ; Wen J; Sun X; Xie Y; Li YP
    Int J Tuberc Lung Dis; 2006 Oct; 10(10):1080-90. PubMed ID: 17044199
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Therapeutic drug monitoring of antimycobacterial drugs in patients with both tuberculosis and advanced human immunodeficiency virus infection.
    Holland DP; Hamilton CD; Weintrob AC; Engemann JJ; Fortenberry ER; Peloquin CA; Stout JE
    Pharmacotherapy; 2009 May; 29(5):503-10. PubMed ID: 19397460
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Outcomes in HIV-infected patients on antiretroviral therapy with tuberculosis.
    Tansuphasawadikul S; Saito W; Kim J; Phonrat B; Dhitavat J; Chamnachanan S; Pitisuttithum P
    Southeast Asian J Trop Med Public Health; 2007 Nov; 38(6):1053-60. PubMed ID: 18613546
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reducing tuberculosis incidence by tuberculin skin testing, preventive treatment, and antiretroviral therapy in an area of low tuberculosis transmission.
    Elzi L; Schlegel M; Weber R; Hirschel B; Cavassini M; Schmid P; Bernasconi E; Rickenbach M; Furrer H;
    Clin Infect Dis; 2007 Jan; 44(1):94-102. PubMed ID: 17143823
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacokinetic interaction between rifampicin and the once-daily combination of saquinavir and low-dose ritonavir in HIV-infected patients with tuberculosis.
    Ribera E; Azuaje C; Lopez RM; Domingo P; Curran A; Feijoo M; Pou L; Sánchez P; Sambeat MA; Colomer J; Lopez-Colomes JL; Crespo M; Falcó V; Ocaña I; Pahissa A
    J Antimicrob Chemother; 2007 Apr; 59(4):690-7. PubMed ID: 17307771
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Reliable effectiveness for years with good long-term tolerance: 10 years nevirapine--a summary].
    MMW Fortschr Med; 2008 Apr; 150 Spec No 1():70. PubMed ID: 19024921
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.